CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-17). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 415 · Search date 2026-07-17 · Methodology v0.6

Black raspberry extract,
does it really help with Blood-pressure control?

30-Second Summary
C
Evidence Grade C · 49 · Safety unknown
A small trial supports the 2,500 mg specification, not hypertension treatment
What the
research shows
In an eight-week RCT of 45 adults with prehypertension, the 2,500 mg/day group had lower 24-hour and nighttime systolic blood pressure than placebo, but the 1,500 mg/day group and most other vascular and inflammatory markers were not significant. Small, dose-selective surrogate evidence supports C with 49 points.
What the
ads claim
The color, polyphenols, and antioxidant image of berries do not automatically establish blood-pressure lowering or cardiovascular protection. The ingredient judged here is black raspberry, Rubus occidentalis. Evidence from red raspberry, R. idaeus, or bokbunja, R. coreanus, is neither mixed with nor transferred to this claim.
*

Useful facts when choosing a product

  • The Korean individually recognized intake for black raspberry extract is 2,500 mg/day.
  • In the pivotal trial, the blood-pressure signal appeared at 2,500 mg/day, not 1,500 mg/day.
  • Korean health-functional and function-labeled products are distributed, but ordinary black raspberry powder or juice is not necessarily equivalent to the recognized extract specification.
  • The pivotal RCT tested R. occidentalis extract; evidence from R. idaeus or R. coreanus is not included in this blood-pressure assessment.
  • No prominent serious safety signal emerged in the short trial, but evidence for pregnancy, lactation, long-term use, and combination with antihypertensive drugs is insufficient.
Gap Measurement · Verdict 415 · C 49
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Jeong 2016 RCT assigned 45 adults with prehypertension to placebo, 1,500 mg/day, or 2,500 mg/day for eight weeks. The high-dose group had reductions in 24-hour and nighttime systolic pressure versus placebo, while most other measurements were not significant. Studies by the same research network examined arterial stiffness and endothelial surrogate markers in metabolic syndrome, but this small trial is the pivotal direct evidence for the blood-pressure claim.

02

Why this is classified as C (49)

Ambulatory blood pressure is a strength, but the evidence is one eight-week trial of 45 people with only selected high-dose systolic outcomes positive, supporting C with 49 points.

Counterpoint. A short-term systolic-pressure signal remains for the 2,500 mg/day standardized extract. This does not establish diastolic-pressure improvement, hypertension treatment, or cardiovascular-event prevention.

Rejudgment record. New verdict — One eight-week RCT of 45 people found positive 24-hour and nighttime systolic pressure at 2,500 mg/day, while the lower dose and most other markers were null

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Jeong HS et al. 2016Randomized double-blind placebo-controlled trial45Participation by a Gochang black-raspberry research institute; detailed funding unclearTwenty-four-hour and day-night blood pressure, central pressure, pulse-wave velocity, and inflammatory markersThe 2,500 mg/day dose reduced 24-hour and nighttime systolic pressure; most other markers were not significant.Key
MFDS individually recognized black raspberry extractRegulatory ingredient informationNot applicableRecognized function and intakeRegistered for helping control blood pressure at 2,500 mg/day.Product information
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-17).

Jeong HS, Hong SJ, Cho JY, et al. Effects of Rubus occidentalis extract on blood pressure in patients with prehypertension: Randomized, double-blinded, placebo-controlled clinical trial. Nutrition. 2016;32(4):461-467. PMID: 26740254. DOI: 10.1016/j.nut.2015.10.014.
checked
Korea Food Industry Cluster Agency. Individually recognized health-functional-food ingredient commercialization table: black raspberry extract, recognition 2022-9, 2,500 mg/day. 2024. No PMID or DOI.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-17 · Corrections: none

Cite this verdict

Black raspberry extract x blood-pressure control Evidence Grade C card
[Chamgap] Black raspberry extract x blood-pressure control — Evidence Grade C·49. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/black-raspberry-extract-blood-pressure/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.